ARCHIVES

J&J To Eliminate Its Ortho Biotech Unit As FDA Considers Further Limits On ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 17 | May 2, 2008

Download PDF Visit The Full Archive

Related Articles

Bill Reintroduced to Weaken U.S. Preventive Services Task Force

July 3, 2013

In Brief: New Arizona Cancer Center Building Dedicated; Free Copies Of FY 1988 Bypass Budget Available

November 7, 1986

Obituary: Ernst Wynder, 77, Linked Smoking, Cancer

July 23, 1999

Harkin, Bumpers Concerned Over Centers Funding

May 5, 1989

Bill Would Require Medicare to Reimburse Costs of Trials

March 7, 1997

Funding Opportunity: NYC-based Research Alliance Offering $200,000 Per Year for Young Investigators

October 3, 2014